Acute Bacterial Skin and Skin Structure Infection
6 clinical trials · Condition
◉ Watch Acute Bacterial Skin and Skin Structure Infection
| Record | Firm | Date |
|---|---|---|
| Retrospective Effectiveness Study of Dalbavancin and Other Standard of Care of the Same Class in Patients With ABSSSI (NCT04298463) | Aziende Chimiche Riunite Angelini Francesco S.p.A | 2020-06-18 |
| Development of Risk Score Model and Decision Tree Algorithm for Predicting Infections With CRKp in Colonized Patients (NCT04229511) | SCARE (Study group for carbapenem resistance) | 2020-04-01 |
| Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients (NCT03873987) | Melinta Therapeutics, Inc. | 2019-07-16 |
| Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) (NCT03233438) | Allergan | 2017-07-24 |
| A Study to Evaluate the Safety of a Single Intravenous (IV) Dose of Orbactiv (Oritavancin) in Participants on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI) (NCT02452918) | The Medicines Company | 2015-09-29 |
Track Acute Bacterial Skin and Skin Structure Infection automatically
Every clearance here is in the API, with alerts when new ones post.